interactions:
- request:
    body: null
    headers:
      Accept:
      - '*/*'
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      User-Agent:
      - python-requests/2.31.0 habanero/1.2.5
      X-USER-AGENT:
      - python-requests/2.31.0 habanero/1.2.5
    method: GET
    uri: https://api.crossref.org/works/10.1371/journal.pone.0033693
  response:
    body:
      string: '{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T17:01:14Z","timestamp":1694019674307},"reference-count":70,"publisher":"Public
        Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,21]],"date-time":"2012-03-21T00:00:00Z","timestamp":1332288000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS
        ONE"],"DOI":"10.1371\/journal.pone.0033693","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T01:00:52Z","timestamp":1332464452000},"page":"e33693","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":63,"title":["Methylphenidate
        Exposure Induces Dopamine Neuron Loss and Activation of Microglia in the Basal
        Ganglia of Mice"],"prefix":"10.1371","volume":"7","author":[{"given":"Shankar","family":"Sadasivan","sequence":"first","affiliation":[]},{"given":"Brooks
        B.","family":"Pond","sequence":"additional","affiliation":[]},{"given":"Amar
        K.","family":"Pani","sequence":"additional","affiliation":[]},{"given":"Chunxu","family":"Qu","sequence":"additional","affiliation":[]},{"given":"Yun","family":"Jiao","sequence":"additional","affiliation":[]},{"given":"Richard
        J.","family":"Smeyne","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2012,3,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/sj.npp.1301164","article-title":"Stimulants:
        Therapeutic actions in ADHD.","volume":"31","author":"AF Arnsten","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/14737175.5.3.325","article-title":"Methylphenidate
        HCl: therapy for attention deficit hyperactivity disorder.","volume":"5","author":"PK
        Capp","year":"2005","journal-title":"Expert Rev Neurother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11940-011-0137-6","article-title":"Recent
        advances in the treatment of narcolepsy.","volume":"13","author":"N Hirai","year":"2011","journal-title":"Curr
        Treat Options Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"L7","DOI":"10.1016\/S0024-3205(99)00225-8","article-title":"Methylphenidate
        and cocaine have a similar in vivo potency to block dopamine transporters
        in the human brain.","volume":"65","author":"ND Volkow","year":"1999","journal-title":"Life
        Sci"},{"key":"ref5","first-page":"1","article-title":"Monitoring the Future
        national survey results on drug use, 1975\u20132010.","author":"LD Johnston","year":"2011"},{"key":"ref6","first-page":"1","article-title":"Monitoring
        the Future national survey results on drug use, 1975\u20132010.","author":"LD
        Johnston","year":"2011"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00213-010-1853-4","article-title":"Non-specific
        effects of methylphenidate (Ritalin) on cognitive ability and decision-making
        of ADHD and healthy adults.","volume":"210","author":"N Agay","year":"2010","journal-title":"Psychopharmacology
        (Berl)"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02244750","article-title":"Cognitive
        effects of milacemide and methylphenidate in healthy young adults.","volume":"115","author":"JA
        Camp-Bruno","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.phrs.2010.04.002","article-title":"Modafinil
        and methylphenidate for neuroenhancement in healthy individuals: A systematic
        review.","volume":"62","author":"D Repantis","year":"2010","journal-title":"Pharmacol
        Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/456702a","article-title":"Towards
        responsible use of cognitive-enhancing drugs by the healthy.","volume":"456","author":"H
        Greely","year":"2008","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00003088-199937060-00002","article-title":"Pharmacokinetics
        and clinical effectiveness of methylphenidate.","volume":"37","author":"HC
        Kimko","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1471-4159.1997.68052032.x","article-title":"Effects
        of methylphenidate on extracellular dopamine, serotonin, and norepinephrine:
        comparison with amphetamine.","volume":"68","author":"R Kuczenski","year":"1997","journal-title":"J
        Neurochem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/syn.20235","article-title":"Therapeutic
        doses of amphetamine or methylphenidate differentially increase synaptic and
        extracellular dopamine.","volume":"59","author":"WK Schiffer","year":"2006","journal-title":"Synapse"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/(SICI)1097-4547(19960215)43:4<439::AID-JNR5>3.0.CO;2-G","article-title":"Dopamine
        receptors mediate differential morphological effects on cerebral cortical
        neurons in vitro.","volume":"43","author":"BS Reinoso","year":"1996","journal-title":"J
        Neurosci Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0006-3223(92)90311-M","article-title":"Neural
        development is regulated by classical neurotransmitters: dopamine D2 receptor
        stimulation enhances neurite outgrowth.","volume":"31","author":"RD Todd","year":"1992","journal-title":"Biol
        Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/exnr.1993.1008","article-title":"Pre-
        and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal
        injection.","volume":"119","author":"F Filloux","year":"1993","journal-title":"Experimental
        Neurology"},{"key":"ref17","first-page":"633","article-title":"Oxidative pathways
        for catecholamines in the genesis of neuromelanin and cytotoxic quinones.","volume":"14","author":"DG
        Graham","year":"1978","journal-title":"Mol Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jnr.490260405","article-title":"Toxicity
        of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.","volume":"26","author":"PP
        Michel","year":"1990","journal-title":"Journal Of Neuroscience Research"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03033137","article-title":"Dopamine-
        or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and
        tyrosinase in a model of Parkinson&apos;s disease.","volume":"5","author":"M
        Asanuma","year":"2003","journal-title":"Neurotox Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1476-5381.1993.tb12847.x","article-title":"Striatal
        dopamine release in vivo following neurotoxic doses of methamphetamine and
        effect of the neuroprotective drugs, chlormethiazole and dizocilpine.","volume":"108","author":"HA
        Baldwin","year":"1993","journal-title":"Br J Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2009.08.060","article-title":"Superoxide
        production after acute and chronic treatment with methylphenidate in young
        and adult rats.","volume":"465","author":"KM Gomes","year":"2009","journal-title":"Neurosci
        Lett"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1016\/j.febslet.2007.09.046","article-title":"Protective
        effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity.","volume":"581","author":"I
        Miyazaki","year":"2007","journal-title":"FEBS Lett"},{"key":"ref23","first-page":"141","article-title":"Dopaminergic
        neuron-specific oxidative stress caused by dopamine itself.","volume":"62","author":"I
        Miyazaki","year":"2008","journal-title":"Acta Med Okayama"},{"key":"ref24","article-title":"Inflammatory
        effects of highly pathogenic H5N1 influenza virus infection in the CNS of
        mice.","author":"H Jang","year":"2012","journal-title":"J Neurosci"},{"key":"ref25","first-page":"382","article-title":"Pharmacokinetics
        of methylphenidate in man, rat and monkey.","volume":"226","author":"W Wargin","year":"1983","journal-title":"J
        Pharmacol Exp Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/1098-2396(20001215)38:4<432::AID-SYN8>3.0.CO;2-Q","article-title":"Synergistic
        interactions between nicotine and cocaine or methylphenidate depend on the
        dose of dopamine transporter inhibitor.","volume":"38","author":"MR Gerasimov","year":"2000","journal-title":"Synapse"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/FBP.0b013e328153daf5","article-title":"Sensitization
        and cross-sensitization after chronic treatment with methylphenidate in adolescent
        Wistar rats.","volume":"18","author":"SS Valvassori","year":"2007","journal-title":"Behav
        Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0006-8993(99)01273-1","article-title":"Differential
        strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
        (MPTP) administration acts in an autosomal dominant fashion: quantitative
        analysis in seven strains of Mus musculus.","volume":"828","author":"K Hamre","year":"1999","journal-title":"Brain
        Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainres.2007.07.067","article-title":"Response
        to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains
        and reveals a divergence in JNK signaling and COX-2 induction prior to loss
        of neurons in the substantia nigra pars compacta.","volume":"1175","author":"JD
        Boyd","year":"2007","journal-title":"Brain Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hup.579","article-title":"Methylphenidate:
        a review of its neuropharmacological, neuropsychological and adverse clinical
        effects.","volume":"19","author":"BE Leonard","year":"2004","journal-title":"Hum
        Psychopharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00005053-199501000-00009","article-title":"Psychiatric
        morbidity in narcoleptics on chronic high dose methylphenidate therapy.","volume":"183","author":"LK
        Pawluk","year":"1995","journal-title":"J Nerv Ment Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jhealeco.2010.07.005","article-title":"Measuring
        inappropriate medical diagnosis and treatment in survey data: The case of
        ADHD among school-age children.","volume":"29","author":"WN Evans","year":"2010","journal-title":"J
        Health Econ"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/chi.0b013e31815a56f1","article-title":"Misuse
        and diversion of stimulants prescribed for ADHD: a systematic review of the
        literature.","volume":"47","author":"TE Wilens","year":"2008","journal-title":"J
        Am Acad Child Adolesc Psychiatry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0166-4328(01)00417-X","article-title":"Changes
        in the second messenger cyclic AMP during development may underlie motoric
        symptoms in attention deficit\/hyperactivity disorder (ADHD).","volume":"130","author":"SL
        Andersen","year":"2002","journal-title":"Behav Brain Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s002130051093","article-title":"Dopamine-transporter
        occupancy after intravenous doses of cocaine and methylphenidate in mice and
        humans.","volume":"146","author":"SJ Gatley","year":"1999","journal-title":"Psychopharmacology
        (Berl)"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/syn.10038","article-title":"Relationship
        between blockade of dopamine transporters by oral methylphenidate and the
        increases in extracellular dopamine: therapeutic implications.","volume":"43","author":"ND
        Volkow","year":"2002","journal-title":"Synapse"},{"key":"ref37","first-page":"259","article-title":"Effects
        of acute and chronic administration of atomoxetine and methylphenidate on
        extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal
        cortex and striatum of mice.","volume":"114","author":"K Koda","year":"2010","journal-title":"J
        Neurochem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1021\/tx960145c","article-title":"Oxidation
        of dopamine in the presence of cysteine: characterization of new toxic products.","volume":"10","author":"XM
        Shen","year":"1997","journal-title":"Chem Res Toxicol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1471-4159.2003.01808.x","article-title":"Dopamine-dependent
        cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration
        in Parkinson&apos;s disease.","volume":"86","author":"HJ Choi","year":"2003","journal-title":"J
        Neurochem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuint.2004.10.009","article-title":"Inhibition
        of vesicular monoamine transporter enhances vulnerability of dopaminergic
        cells: relevance to Parkinson&apos;s disease.","volume":"46","author":"HJ
        Choi","year":"2005","journal-title":"Neurochem Int"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1046\/j.1471-4159.2001.00125.x","article-title":"Reaction
        of oxidized dopamine with endogenous cysteine residues in the human dopamine
        transporter.","volume":"76","author":"RE Whitehead","year":"2001","journal-title":"J
        Neurochem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.neuroscience.2005.09.035","article-title":"Adult
        and in utero exposure to cocaine alters sensitivity to the Parkinsonian toxin
        1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","volume":"137","author":"SA
        Lloyd","year":"2006","journal-title":"Neuroscience"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s11064-007-9544-1","article-title":"Antioxidant
        enzyme activities following acute or chronic methylphenidate treatment in
        young rats.","volume":"33","author":"KM Gomes","year":"2008","journal-title":"Neurochem
        Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brainres.2006.01.004","article-title":"Methylphenidate
        treatment induces oxidative stress in young rat brain.","volume":"1078","author":"MR
        Martins","year":"2006","journal-title":"Brain Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3727\/000000006783981990","article-title":"Progressive
        dopamine neuron loss in Parkinson&apos;s disease: the multiple hit hypothesis.","volume":"15","author":"PM
        Carvey","year":"2006","journal-title":"Cell Transplant"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1289\/ehp.7570","article-title":"Developmental
        pesticide models of the Parkinson disease phenotype.","volume":"113","author":"DA
        Cory-Slechta","year":"2005","journal-title":"Environ Health Perspect"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/1073858408319974","article-title":"Etiopathogenesis
        of Parkinson disease: a new beginning?","volume":"15","author":"L Weidong","year":"2009","journal-title":"Neuroscientist"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF03036449","article-title":"MPTP
        and SNpc DA neuronal vulnerability: role of dopamine, superoxide and nitric
        oxide in neurotoxicity. Minireview.","volume":"7","author":"V Jackson-Lewis","year":"2005","journal-title":"Neurotox
        Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10072-008-0986-2","article-title":"Targeting
        reactive oxygen species, reactive nitrogen species and inflammation in MPTP
        neurotoxicity and Parkinson&apos;s disease.","volume":"29","author":"H Yokoyama","year":"2008","journal-title":"Neurol
        Sci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/ars.2005.7.685","article-title":"Reactive
        oxygen and nitrogen species: weapons of neuronal destruction in models of
        Parkinson&apos;s disease.","volume":"7","author":"S Przedborski","year":"2005","journal-title":"Antioxid
        Redox Signal"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2011.06.013","article-title":"Increased
        risk of Parkinson&apos;s disease in individuals hospitalized with conditions
        related to the use of methamphetamine or other amphetamine-type drugs.","volume":"120","author":"RC
        Callaghan","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1523\/JNEUROSCI.19-07-02424.1999","article-title":"Increased
        methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter
        2 knock-out mice.","volume":"19","author":"F Fumagalli","year":"1999","journal-title":"J
        Neurosci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1096\/fj.00-0205rev","article-title":"The
        VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac
        arrhythmias, aging, and vulnerability to dopaminergic toxins.","volume":"14","author":"GR
        Uhl","year":"2000","journal-title":"Faseb J"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1523\/JNEUROSCI.19-23-10289.1999","article-title":"Peroxynitrite
        inactivation of tyrosine hydroxylase: mediation by sulfhydryl oxidation, not
        tyrosine nitration.","volume":"19","author":"DM Kuhn","year":"1999","journal-title":"J
        Neurosci"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F","article-title":"Dopamine,
        in the presence of tyrosinase, covalently modifies and inactivates tyrosine
        hydroxylase.","volume":"54","author":"Y Xu","year":"1998","journal-title":"J
        Neurosci Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence
        of active nerve cell degeneration in the substantia nigra of humans years
        after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.","volume":"46","author":"JW
        Langston","year":"1999","journal-title":"Ann Neurol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.reprotox.2007.01.007","article-title":"The
        gestational environment and Parkinson&apos;s disease: evidence for neurodevelopmental
        origins of a neurodegenerative disorder.","volume":"23","author":"BK Barlow","year":"2007","journal-title":"Reprod
        Toxicol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/mds.23263","article-title":"Incidence
        of Parkinson&apos;s disease among hospital patients with methamphetamine-use
        disorders.","volume":"25","author":"RC Callaghan","year":"2010","journal-title":"Mov
        Disord"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-211-73574-9_38","article-title":"Association
        of Parkinson&apos;s disease with symptoms of attention deficit hyperactivity
        disorder in childhood.","author":"S Walitza","year":"2007","journal-title":"J
        Neural Transm Suppl"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1542\/peds.63.6.847","article-title":"The
        effects of stimulant medication on the growth of hyperkinetic children.","volume":"63","author":"AF
        Croche","year":"1979","journal-title":"Pediatrics"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/1044546041649066","article-title":"Weekend
        holidays during methylphenidate use in ADHD children: a randomized clinical
        trial.","volume":"14","author":"S Martins","year":"2004","journal-title":"J
        Child Adolesc Psychopharmacol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-4328(01)00433-8","article-title":"Pharmacokinetic
        and pharmacodynamic properties of stimulants: implications for the design
        of new treatments for ADHD.","volume":"130","author":"JM Swanson","year":"2002","journal-title":"Behav
        Brain Res"},{"key":"ref63","article-title":"The Mouse Brain in Stereotaxic
        Coordinates","author":"G Paxinos","year":"2001"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.neuroscience.2009.04.031","article-title":"A
        comparison of model-based (2D) and design-based (3D) stereological methods
        for estimating cell number in the substantia nigra pars compacta (SNpc) of
        the C57BL\/6J Mouse.","volume":"161","author":"ZC Baquet","year":"2009","journal-title":"Neuroscience"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","article-title":"Unbiased
        stereological estimation of the total number of neurons in thesubdivisions
        of the rat hippocampus using the optical fractionator.","volume":"231","author":"MJ
        West","year":"1991","journal-title":"Anat Rec"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00401-009-0622-0","article-title":"Microglia:
        biology and pathology.","volume":"119","author":"MB Graeber","year":"2010","journal-title":"Acta
        Neuropathol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1126\/science.1190929","article-title":"Changing
        face of microglia.","volume":"330","author":"MB Graeber","year":"2010","journal-title":"Science"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":"Summaries
        of Affymetrix GeneChip probe level data.","volume":"31","author":"RA Irizarry","year":"2003","journal-title":"Nucleic
        Acids Res"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting
        batch effects in microarray expression data using empirical Bayes methods.","volume":"8","author":"WE
        Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"Article3","DOI":"10.2202\/1544-6115.1027","article-title":"Linear
        models and empirical bayes methods for assessing differential expression in
        microarray experiments.","volume":"3","author":"GK Smyth","year":"2004","journal-title":"Stat
        Appl Genet Mol Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0033693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T08:12:10Z","timestamp":1641456730000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0033693"}},"subtitle":[],"editor":[{"given":"Cesario
        V.","family":"Borlongan","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2012,3,21]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,21]]}},"URL":"http:\/\/dx.doi.org\/10.1371\/journal.pone.0033693","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":["Multidisciplinary"],"published":{"date-parts":[[2012,3,21]]}}}'
    headers:
      access-control-allow-headers:
      - X-Requested-With, Accept, Accept-Encoding, Accept-Charset, Accept-Language,
        Accept-Ranges, Cache-Control
      access-control-allow-origin:
      - '*'
      access-control-expose-headers:
      - Link
      connection:
      - close
      content-encoding:
      - gzip
      content-length:
      - '7047'
      content-type:
      - application/json
      date:
      - Mon, 25 Sep 2023 04:29:19 GMT
      permissions-policy:
      - interest-cohort=()
      server:
      - Jetty(9.4.40.v20210413)
      vary:
      - Accept-Encoding
      x-api-pool:
      - public
      x-rate-limit-interval:
      - 1s
      x-rate-limit-limit:
      - '50'
      x-ratelimit-interval:
      - 1s
      x-ratelimit-limit:
      - '50'
    status:
      code: 200
      message: OK
version: 1
